Imprivata and Connected Technology Solutions (CTS) Partner to Enable Positive Patient Identification at Registration Kiosks

Submit the press release

Integrated solution gives thousands of hospitals and medical facilities a single patient identifier for fast, secure self-service patient check-in

Lexington, Mass./Orlando, FL—February 22, 2017—Imprivata®, the healthcare IT security company, and Connected Technology Solutions (CTS), today announced a partnership to enable positive patient identification at self-service registration kiosks. Imprivata PatientSecure® eliminates the need for providers and patients to input patient information manually by integrating with CTS kiosks to make the single patient identifier available through kiosk registration.

According to the 2016 National Patient Misidentification Report from the Ponemon Institute, 63 percent of top-level U.S. healthcare executives and care providers say that the primary cause of patient misidentification is incorrect identification at the registration desk. To help eliminate patient identification errors at the source, Imprivata PatientSecure allows hospitals to identify patients through a biometric palm vein scan at CTS kiosks, rather than requiring manual input of patient information, verifying their medical information, co-pay collection, insurance validation, and more.  

Since deploying our palm vein biometric identification platform, we have significantly reduced registration errors and lowered our duplicate medical record rate to 0.01 percent of our patient census, which is 80 times better than the national average,” said Craig Richardville, Chief Information & Analytics Officer at Carolinas Healthcare System. “Now that we’re able to integrate this technology directly into our registration kiosks, we expect increased improvement in our front-end patient registration process, which will further enhance our overall revenue cycle management operation and patient experience.”

CTS leads the kiosk industry with purpose-built and specifically designed kiosk units for patient check-in. Embedding positive patient identification into CTS kiosks ensures accurate patient identification at check-in, and also improves insurance validation, collection of co-pays, and form fulfilment, addressing evolving patient needs while helping to drive new efficiencies in healthcare.

“The use of biometric identification at registration kiosks is a great addition to our solutions and helps transform the entire registration and intake process, working directly with the Epic EHR,” said Marc Avallone, Vice President of Sales & Business Development at CTS. “Integrating Imprivata PatientSecure palm-vein biometrics with our kiosks has sped up the patient identification process and assures positive patient identification every time. This improves patient safety, overall registration throughput, and ultimately enhances the entire patient experience.”

Imprivata PatientSecure is the positive patient identification platform for healthcare that eliminates patient misidentification at any point of entry or care and positively identifies patients to improve patient safety, increase revenue capture, and prevent identity theft. Beyond identification at registration, Imprivata PatientSecure helps hospitals to re-identify patients throughout their healthcare experience at points of care including medication administration, radiation oncology treatments, and blood transfusions.

“Deep integrations with self-service kiosks, EHRs, and other digital health technologies are critical to ensuring positive patient identification at all points of care across the healthcare continuum,” said Justyna Evlogiadis, Senior Product Marketing Manager at Imprivata. “By partnering with CTS, we’re ensuring that patients are accurately identified and experience the best possible patient registration workflows, ultimately improving patient adoption of self-service kiosks as well as patient safety and revenue cycle performance.”

The joint Imprivata and CTS solution is on display this week at the HIMSS17 Conference and Exhibition (February 20-22, 2017 in Orlando, Florida) in Imprivata booth #747 and CTS booth #1123.

About Imprivata

Imprivata®, the healthcare IT security company, provides healthcare organizations globally with a security and identity platform that delivers authentication management, fast access to patient information, secure communications, and positive patient identification. Imprivata enables care providers to securely and efficiently access, communicate, and transact patient health information to address critical compliance and security challenges while improving productivity and the patient experience. For more information, please visit www.imprivata.com.

About Connected Technology Solutions (CTS)

Connected Technology Solutions (CTS) is the healthcare industry’s #1 provider in patient check-in solutions. The CTS flagship patient check-in kiosk, the Patient Passport Express™ (PPE) is not only aesthetically pleasing to the eyes but features a full 40” range of vertical motion. This is the only fully compliant wheelchair-accessible patient check-in kiosk unit available in the U.S. The PPE’s are deployed across the United States, with over 200 million patient check-in transactions to date. Visit us at http://www.ctshealthcare.com for more information on how we can help you.

Evaluating a Therapy for Rare Midgut Tumors

Submit the press release

Al Benson, MD, professor of Medicine in the Division of Hematology/Oncology, was a co-author of the paper, which evaluated a therapy for advanced midgut neuroendocrine tumors.

An experimental drug improved progression-free survival rates for patients with advanced midgut neuroendocrine tumors — a rare cancer of the small intestine and colon — over a standard therapy, according to a recent global phase III clinical trial. Northwestern Medicine was a major participant in the trial, including faculty from the Division of Hematology/Oncology and faculty specializing in nuclear medicine.

The study, published in the New England Journal of Medicine, was co-authored by Al B. Benson III, MD, FACP, FASCO, professor of Medicine in the Division of Hematology/Oncology and associate director for cooperative groups at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Patients with midgut neuroendocrine tumors are typically first treated with a somatostatin analogue. But if they experience disease progression after such therapy, there are limited options for second-line treatment. Five-year survival rates for patients with metastatic disease are estimated to be less than 50 percent.

In the current trial, investigators randomly assigned 229 patients with a progressive form of the disease to receive either a higher dose of a somatostatin analogue called octreotide long-acting repeatable (LAR) or a drug called 177Lu-Dotatate, plus standard care. 177Lu-Dotatate, which is not yet commercially available in the United States, is a type of peptide receptor radionuclide therapy (PRRT), a targeted treatment that delivers radiation directly to tumor cells.

The investigators found that patients in the 177Lu-Dotatate group had noticeably improved outcomes. Trial participants who received 177Lu-Dotatate had a 65.2 percent estimated rate of progression-free survival by month 20, compared to 10.8 percent for those treated with octreotide LAR alone. Furthermore, 177Lu-Dotatate showed an 18 percent response rate, compared to 3 percent in the control group.

Overall, the relative risk of disease progression or death for patients who were assigned 177Lu-Dotatate was 79 percent lower than the risk with high-dose octreotide LAR.

The most common adverse effects were nausea and vomiting — a result of simultaneous infusions of nephroprotective amino acids — and there was no evidence of kidney damage.

The drug has been submitted for FDA approval.

“Northwestern Medicine is a major site for the treatment of neuroendocrine tumors,” Benson said. “Upon FDA approval, we look forward to being able to routinely offer our patients this therapy as an important advancement in care.

The research was supported by Advanced Accelerator Applications, which developed the drug. Benson reported grant support from Advanced Accelerator Applications during the conduct of the study.

New method reduces adverse effects of rectal cancer treatment

Submit the press release

Karolinska Institutet's picture

Printer-friendly versionPrinter-friendly version

Fri, Feb 10, 2017 02:00 EST

A new study from Karolinska Institutet shows that short-course preoperative radiotherapy combined with delayed surgery reduces the adverse side-effects of rectal cancer surgery without compromising its efficacy. The results are presented in the journal  The Lancet Oncology .

Rectal cancer affects some 2,000 men and women in Sweden every year. Preoperative radiotherapy was gradually introduced in the early 1990s, with a consequent improvement in prognosis for people with rectal cancer and reduction in the risk of local recurrence.

Back then we showed that preoperative radiotherapy reduces the risk of local recurrence by over 50 per cent for patients with rectal cancer,” says principal investigator Anna Martling, senior consultant surgeon and professor at Karolinska Institutet’s Department of Molecular Medicine and Surgery. “Thanks to our results, radiotherapy is recommended to many rectal cancer patients.”

However, radiotherapy can cause adverse reactions and the optimal radiotherapeutic method and the interval between it and the ensuing surgery have been mooted.

The study now presented in The Lancet Oncology is based on the claim that the adverse effects of rectal cancer treatment can be reduced by administering more but lower doses of radiation for a longer time, or by increasing the interval between radiotherapy and surgery. These hypotheses have now been tested in a study in which rectal cancer patients were randomly assigned to three different treatment arms:

  • Standard therapy, i.e. short-course (5×5 Gy) radiotherapy with direct surgery within a week.

  • Delayed surgery with short-course (5×5 Gy) radiotherapy followed by surgery after 4-8 weeks.

  • Delayed surgery with long-course (25×2 Gy) radiotherapy followed by surgery after 4-8 weeks.

The results of the study show that patients with delayed surgery develop fewer complications with equally good oncological outcomes. It also showed that there is no difference between long-course and short-course radiotherapy other than that the former considerably lengthens the time for treatment.

“The results of the study will give rise to improved therapeutic strategies, fewer complications with a sustained low incidence of local recurrence, and better survival rates for rectal cancer patients,” says Professor Martling. “The results can now be immediately put to clinical use to the considerable benefit of the patients.”

Eighteen Swedish hospitals took part in the study, which was financed by the Swedish Research Council and the Cancer Society in Stockholm, and through the regional ALF agreement between Stockholm County Council and Karolinska Institutet. Researchers from the universities in Lund, Uppsala and Linköping also contributed to findings.

Publication:  Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial ’,  Johan Erlandsson, Torbjörn Holm, David Pettersson, Åke Berglund, Björn Cedermark, Calin Radu, Hemming Johansson, Mikael Machado, Fredrik Hjern, Olof Hallböök, Ingvar Syk, Bengt Glimelius, Anna Martling,  The Lancet Oncology , online 9 February 2017 .

For further information, please contact:
Professor Anna Martling, MD, PhD
Phone: +46 (0)760-505797
E-mail anna.martling@ki.se  

Contact the Press Office and download images

More reading about Professor Martling’s research

Karolinska Institutet is one of the world’s leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.

Copy this html code to your website/blog to embed this press release.

Art Rosenfeld, California’s Godfather of Energy Efficiency, 90

Submit the press release

Art Rosenfeld in his Berkeley Lab office in 1989 (credit: Lawrence Berkeley National Laboratory)

Art Rosenfeld in his Berkeley Lab office in 1989 (credit: Lawrence Berkeley National Laboratory)

Art Rosenfeld, a Lawrence Berkeley National Laboratory (Berkeley Lab) Distinguished Scientist Emeritus who is also known as California’s “godfather” of energy efficiency and who has been credited with being personally responsible for billions of dollars in energy savings, died Friday at his home in Berkeley, California. He was 90.

A particle physicist who decided one evening four decades ago to turn off unused lights in his Berkeley Lab office building, Rosenfeld went on to create the field of energy efficiency, inspire an entire generation of energy researchers, and conduct the rigorous engineering analyses that would lead to breakthroughs in low-energy lighting, windows, refrigerators, buildings, and many other areas, while convincing utilities and policymakers that new power plants—and their accompanying greenhouse gas emissions—were not necessary.

“Art’s leadership in the field of energy efficiency truly shaped the way an entire generation of researchers and policymakers worked together to conserve resources,” said Berkeley Lab Director Mike Witherell. “He helped enlarge the vision of what a national lab can do—for the great benefit of humankind.”

The term “Rosenfeld effect” was coined to explain why California’s per capita electricity usage has remained flat since the mid-1970s while U.S. usage has climbed steadily and is now 50 percent higher than it was 40 years ago. He is also behind “Rosenfeld’s Law,” which states that the amount of energy required to produce one dollar of economic output has decreased by about 1 percent per year since 1845.16-PA-2345_Rosenfeld_Effect_r4-01

His many admirers included former Secretary of Energy Steve Chu, who has called him a “hero.” “Art was one of the most decent, generous, engaging, passionate, and thoughtful people that I have known. His wonderful persistence in asking interesting, important questions and being completely open to new ideas makes him a compelling colleague,” Chu said. “The climate crisis has given his work even greater significance. Indeed, it is no exaggeration to say that the field Art pioneered is now indispensable in how we transition to a sustainable future.”

Rosenfeld was famous for his detailed calculations, but he also had a knack for translating the results into terms that could be easily understood. For the layperson, results were expressed not in scientific units but in terms of equivalencies, such as how many cars would be taken off the road or how many power plants that would not need to be built. In 2010, 54 scientists from 26 institutions around the world co-authored a paper proposing the “Rosenfeld,” a unit of measurement to express that very concept—they defined the Rosenfeld as electricity savings of 3 billion kilowatt-hours per year, the amount needed to replace the annual generation of a 500 megawatt coal-fired power plant.

Awards and accolades It was a concept he liked to use with politicians and policymakers—to great effect. In 1976 he pointed out to Gov. Jerry Brown that a proposed nuclear power plant would not be needed if refrigerators were required to be more efficient. As a result, the proposed plant was not built, and the following year standards for new refrigerators and freezers went into effect.

“He gave validation to the very unorthodox notion that economic growth could be decoupled from energy growth,” Brown told the Los Angeles Times in 2010. “He was really the guru of efficiency.”

Art Rosenfeld at the Fermi Award ceremony in 2006 (credit: Lawrence Berkeley National Laboratory)

Art Rosenfeld at the Fermi Award ceremony in 2006 (credit: Lawrence Berkeley National Laboratory)

As the energy savings accumulated, so did recognition for his work. He received the Szilard Award for Physics in the Public Interest in 1986, the Carnot Award for Energy Efficiency from the Department of Energy in 1993, and the Berkeley Citation in 2001 from the University of California.

In 2006 he won the Enrico Fermi Award, one of the nation’s oldest and most prestigious awards for scientific achievement. In 2010 he was awarded the Global Energy International Prize, established by Russian scientists in 2002. That year he was also voted into the National Academy of Engineering.

In 2012 Pres. Obama named him one of 11 recipients of the National Medal of Technology and Innovation, one of the highest honors bestowed by the United States Government upon scientists, engineers, and inventors.

And just last year the Tang Prize Foundation announced that it was awarding to Rosenfeld its 2016 prize in Sustainable Development “for his lifelong and pioneering innovations in energy efficiency resulting in immense reductions in energy consumption and greenhouse gas emissions around the world.”

Turning off the lights Rosenfeld was born in Alabama in 1926. He served in the U.S. Navy for two years at the end of World War II, then entered graduate school at the University of Chicago, where he became, as he often said, “Enrico Fermi’s last graduate student.” On the strength of a recommendation from Fermi, he later moved to Berkeley in the 1950s to work as a physicist in the Nobel Prize-winning particle physics group of Luis Alvarez.

Rosenfeld played a key role in the development of the hydrogen bubble chambers Alvarez was building to detect particles produced in the new Bevatron at what was then called the Radiation Laboratory (now Lawrence Berkeley National Laboratory). They identified a dozen new particles, and when Alvarez was awarded the Nobel Prize in Physics in 1968, he invited Rosenfeld and others in the lab to Stockholm for the celebration.

Five years later Rosenfeld was leading the old Alvarez group when the OPEC oil embargo struck. Late one Friday evening in 1973, while sitting at the office and thinking about the half hour he would have to wait in line the next day to buy gas, he decided to calculate how much energy could be saved by turning off unused lights. That was the turning point.

“After 20 minutes of uncovering light switches (and saving 100 gallons for the weekend), I decided that UC Berkeley and its Radiation Laboratory should do something about conservation,” he wrote in a 1999 autobiography of his career, “The Art of Energy Efficiency.”

Soon he switched his focus to energy and the environment full time. He founded the Center for Building Science at Berkeley Lab in 1975, where a broad range of energy efficiency standards and technologies were developed under his 20-year leadership. These include electronic ballasts for fluorescent lighting–a key component of compact fluorescent lamps (CFLs)–and a transparent coating for window glass that blocks heat from either escaping (winter) or entering (summer). He was personally responsible for developing the DOE-1 and DOE-2 series of computer programs for building energy analysis and design that were incorporated in California’s building energy efficiency standard in 1978. The DOE-2 series has served as the national standard of building energy analysis for 25 years.

His career shift was not without controversy. Some thought it was unwise to abandon a promising physics career while others wanted him fired. The criticisms served only to harden his resolve.

As he wrote in the 1999 article, his calculations questioning the need for more power plants in 1975 angered the utilities: “PG&E called LBNL’s then-director Andy Sessler to complain that physicists were unqualified to project electricity-demand scenarios and to suggest that I be fired. Because my wife and my colleagues, including Sessler, had been telling me that I was overqualified to work on energy efficiency, I found the PG&E complaint somewhat comforting.”

In 1980 Rosenfeld and a few others decided to form a nonprofit think tank, the American Council for an Energy Efficiency Economy (ACEEE), “in cold fury at President Carter,” as he put it. “In his first budget he proposed $88 billion for alternative fuels, and for conservation he proposed a sweater. So we proposed to do a study.” ACEEE continues to play a leading role in federal energy policy.

From scientist to policy advisor, and back again Rosenfeld has influenced and inspired legions of energy researchers. Many still recall wandering into one of his classes and deciding to switch or re-focus their career. His graduate students and those he has worked with and mentored are now leading energy researchers at institutions all over the country, from Berkeley Lab and Stanford University to the Natural Resources Defense Council and the Energy Foundation.

“He was always a model of how to be true to the science and how to work on problems of social significance that are on the cutting edge of science at the same time,” said Ashok Gadgil, a former grad student of Rosenfeld’s who is now deputy of the Energy Technologies Area at Berkeley Lab. “He’s been a role model not just to me but to literally hundreds of other people.”

Art Rosenfeld with his daughter, Margaret, and grandchildren at The "Rosenfeld Effect" Energy Symposium at UC Berkeley in 2006 (credit: CEC)

Art Rosenfeld with his daughter, Margaret, and grandchildren at The “Rosenfeld Effect” Energy Symposium at UC Berkeley in 2006 (credit: CEC)

Nearing 70 years old when Bill Clinton came to office, he was nowhere near ready to retire. Instead, seeing some old friends taking on government jobs, “I began to catch a case of Potomac fever,” he wrote. In 1994 he moved east to serve in the Clinton Administration as a Senior Advisor to the Department of Energy’s Assistant Secretary for Energy Efficiency and Renewable Energy, where he worked on climate change and low-carbon technologies.

In 2000 California Gov. Gray Davis appointed him Commissioner at the California Energy Commission (CEC), and in 2005 he was reappointed by Gov. Arnold Schwarzenegger. As Secretary of Energy, Chu appointed him in 2010 to serve on the Secretary of Energy Advisory Board.

After 10 years on the CEC Rosenfeld returned to Berkeley Lab in 2010 to the Heat Island Group he helped launch in 1985. Its mission is to investigate how cooler surfaces can help cool cities while also cooling the planet. In recent years he was a vocal advocate for cool roofs, co-authoring several papers on how cool roofs can offset carbon dioxide emissions and mitigate global warming. In total he has authored or co-authored more than 400 refereed publications or book chapters.

Rosenfeld is survived by his two daughters, Dr. Margaret Rosenfeld and Dr. Anne Hansen, and six grandchildren. His wife of 53 years, Roz, passed away in 2009.

The family plans to hold a memorial for the community in the summer. This page will be updated when details are available.

# # #

Lawrence Berkeley National Laboratory addresses the world’s most urgent scientific challenges by advancing sustainable energy, protecting human health, creating new materials, and revealing the origin and fate of the universe. Founded in 1931, Berkeley Lab’s scientific expertise has been recognized with 13 Nobel prizes. The University of California manages Berkeley Lab for the U.S. Department of Energy’s Office of Science. For more, visit www.lbl.gov.

View Art Rosenfeld speaking at a Berkeley Lab Science at the Theater event, “Cool Cities, Cool Planet,” in 2010.

For more please visit artrosenfeld.lbl.gov.

Global Titanium Dioxide Nanomaterials Market to Grow at a High CAGR of around 9.42% by 2020- Key Vendors, Trends, Challenges, and Drivers

Submit the press release

Titanium Dioxide Nanomaterials Market report 2016-2020 focuses on the major drivers and restraints for the key players. Titanium Dioxide Nanomaterials research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.  The Titanium Dioxide Nanomaterials market research report is a professional and in-depth study on the current state of Titanium Dioxide Nanomaterials Industry.

Analysts forecast the global Titanium Dioxide Nanomaterials market to grow at a CAGR of 9.42% during the period 2016-2020.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Global Titanium Dioxide Nanomaterials market research report @ http://www.360marketupdates.com/10293155

The Titanium Dioxide Nanomaterials Market research report covers the present scenario and the growth prospects of the global Titanium Dioxide Nanomaterials industry for 2016-2020.

Since the advent of nanotechnology, titanium dioxide nanomaterials have been at the center of research because of their low price and simple production process. These nanomaterials are synthesized at various purity levels from 75% to 99.97% and with diameters ranging from 5 nanometers to 250 nanometers. Although these nanomaterials are used in the commercial and industrial sectors, most of them are produced for skin care products, where they provide protection from UV radiation. They are also used as pigments or thickeners in many personal care products as pigments in paints and coatings, and in the production of solar cells in the energy sector. As these nanomaterials can degrade some types of pollutants, they are also being used to reduce atmospheric nitrous emissions through selective catalytic reduction systems.

Key Vendors of Titanium Dioxide Nanomaterials Market:

  • American Elements
  • EPRUI Nanomaterials and Microspheres
  • Reinste
  • Sigma-Aldrich
  • US Research Nanomaterials

And many more…

Get Sample PDF of Titanium Dioxide Nanomaterials Market Report@

http://www.360marketupdates.com/enquiry/request-sample/10293155

Titanium Dioxide Nanomaterials market report provides key statistics on the market status of the Titanium Dioxide Nanomaterials manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Titanium Dioxide Nanomaterials industry.

The Titanium Dioxide Nanomaterials market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the market. Titanium Dioxide Nanomaterials market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.

Regions of Titanium Dioxide Nanomaterials market:

  • Americas
  • APAC
  • Europe
  • MEA

Through the statistical analysis, the report depicts the global Titanium Dioxide Nanomaterials market including capacity, production, production value, cost/profit, supply/demand and import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

Purchase Report @ http://www.360marketupdates.com/purchase/10293155

Key questions answered in Titanium Dioxide Nanomaterials market report:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

For Any Query, Contact Our Expert @ http://www.360marketupdates.com/enquiry/pre-order-enquiry/10293155

Market driver

  • Increasing acceptance of UVA/B filters in sunscreens and sun protection cosmetics

Market challenge

  • Production constraints on titanium dioxide nanosheets and nanospheres

Market trend

  • Increase in penetration of doped and coated titanium dioxide nanomaterials

The report then estimates 2016-2020 market development trends of Titanium Dioxide Nanomaterials market. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Titanium Dioxide Nanomaterials market before evaluating its feasibility.

Price of Report: $2500 (Single User License)

Ask for Discount @ http://www.360marketupdates.com/enquiry/request-discount/10293155

List of Exhibits in Titanium Dioxide Nanomaterials market report:

  • Exhibit 01: Product offerings
  • Exhibit 02: Impact of drivers
  • Exhibit 03: Impact of drivers and challenges
  • Exhibit 04: Key countries in each region
  • Exhibit 05: Global Titanium Dioxide Nanomaterials market shares by geographies 2015
  • Exhibit 06: Global Titanium Dioxide Nanomaterials market shares by geographies 2020
  • Exhibit 07: Geographical segmentation by revenue 2015

And continued….

 

About 360 Market Updates:
360 Market Sales Updates is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

 

Contact–
Mr. Ameya Pingaley
360 Market Sales Updates
+1 408 520 9750
Email – sales@360Marketupdates.com

 

New Research Details Long-Term Mesothelioma Survival with EPP and IMRT, According to Surviving Mesothelioma

Submit the press release

IMRT radiation for mesothelioma

IMRT for Mesothelioma Surgery Patients?

MRT following EPP achieved excellent local control for MPM, that might lead to the long-term survival in selected patients.

Scientists at Kyoto University say pleural mesothelioma patients who receive intensity modulated radiotherapy after radical surgery may have a chance for extended mesothelioma survival. Surviving Mesothelioma has just published an article on the new research. Click here to read it now.

In the new study, 21 pleural mesothelioma patients were prescribed a dose of 50.4 Gy of radiation delivered to the margins of their tumor resection sites with highly precise IMRT.

Although 15 patients developed radiation-related toxicities, some of them severe, more than a third of patients (37%) were still alive three years after treatment.

“IMRT following EPP achieved excellent local control for MPM, that might lead to the long-term survival in selected patients,” writes study author Yukinori Matsuo.

In spite of the fact that three of the mesothelioma patients experienced an amazing 5+ year survival, Matuso and his colleagues say the potential toxic effects of IMRT need to be seriously considered before implementing this mesothelioma treatment approach.

“All mesothelioma treatments have their plusses and minuses, but it is exciting to note the long-term survival experienced by a few of the patients in this small study,” says Alex Strauss, Managing Editor for Surviving Mesothelioma. “Our goal is always to empower patients and families with the information they need to make the best mesothelioma treatment decisions.”

To read the details of the Japanese study, see Mesothelioma Patients See Long-Term Survival with EPP and IMRT, now available on the Surviving Mesothelioma website.

Matsuo, Y, “Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma”, January 24, 2017, Acta Oncologica, Epub ahead of print, http://www.tandfonline.com/doi/full/10.1080/0284186X.2017.1279749

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

Environmental Monitoring Instrument Market 2017 Market Growth, Trends, Demand, Share, Analysis to 2021

Submit the press release

Environmental Monitoring Instrument Market Production, Supply, Sales, and Demand Research Report is a systematically conducted exhaustive study of the Environmental Monitoring Instrument market. The aim of the Environmental Monitoring Instrument Market report is to assist novice as well as seeded players in gaining astute business intelligence and make apt decisions based on it.

Detailed TOC and Charts & Tables of Environmental Monitoring Instrument Market Research Report available at- http://www.absolutereports.com/10545138  

The analysis in the Environmental Monitoring Instrument Market report is of a two-fold perspective, production and sales. This commercial study encompasses detailed investigation of production, supply, sales, demand, price, cost, income and revenue on Environmental Monitoring Instrument Market in Major Regions.

Split by applications, this report focuses on sales, market share and growth rate of Environmental Monitoring Instrument in each application, can be divided into

  • Indoor Environment Monitoring
  • Outdoor Environment Monitoring

The report analyses the entire production and supply chain of the Market and provides information as per different phases. Whereas, on the basis of sales, data related to sales volume, sales price, cost, sales income, and profit margin etc. of Environmental Monitoring Instrument Market used in different fields, sold in different regions and by different companies is provided in this report.

Major Key Players are Analyzed in the Environmental Monitoring Instrument Market Report such as:

  • Shimadzu
  • Thermo Fisher Scientific
  • Emerson
  • Siemens
  • SICK
  • HORIBA Group
  • HACH……and Others

Get a Sample of Environmental Monitoring Instrument market research report from- http://www.absolutereports.com/enquiry/request-sample/10545138 

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

  • Air and Exhaust Gas Monitoring Instruments
  • Pollution and Environmental Water Quality Monitoring Instruments
  • Portable Field Emergency Monitoring Instrument
  • Electromagnetic Radiation and Radioactive Monitoring Instruments

Market Segment by Regions, this Environmental Monitoring Instrument market report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Environmental Monitoring Instrument Market from 2011 to 2021 (forecast), like:

  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India

No. of Report Pages: 120

Price (Single User Licence): $ 4000

Have any Query Regarding this Report? Contact us at: http://www.absolutereports.com/enquiry/pre-order-enquiry/10545138 

This Environmental Monitoring Instrument Market report also takes into account the past price of 2011-2016 and future price of 2017-2021 as per the supply-demand relation along with perspectives and Environmental Monitoring Instrument market forecasts. Additionally, the Environmental Monitoring Instrument Market report also discusses the data on deals (distributors) and buyers, providing a holistic insight into the supply chain and sales details of Environmental Monitoring Instrument Market.

Several important topics included in the Environmental Monitoring Instrument market research report are as follows:

  •  Overview of Environmental Monitoring Instrument Market
  •  Market Size (Value and Volume) analysis of Environmental Monitoring Instrument Market
  •  Environmental Monitoring Instrument Market Competition by Manufacturers, Type and Application
  •  Environmental Monitoring Instrument Market Major Regions Volume, Value and Sales Price Analysis
  •  Environmental Monitoring Instrument Market Technology and Development Trend
  •  Research Findings and Conclusion of Environmental Monitoring Instrument Market

Buy the Report at: http://www.absolutereports.com/purchase/10545138 

To sum it up, the report concludes with an all-inclusive research result on the Market chain of Environmental Monitoring Instrument Market facilitating the market participants in making well-informed strategic decisions.

About Absolute Reports:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.

Contact–

Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email – [email protected] 

www.absolutereports.com  

Get More Market Research Related News, visit http://www.instapressrelease.com/

ZOLL to Showcase Expanded Portfolio of Advanced Resuscitation and Acute Critical Care Technologies at Arab Health 2017

Submit the press release

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that its expanded and fully integrated portfolio of resuscitation and acute critical care technologies and data management solutions will be on display during Arab Health in Booth G19, Hall 1, 30 January 2 February in Dubai. ZOLL’s products are uniquely capable of helping customers achieve the recommendations in the 2015 American Heart Association Guidelines, which are followed by many countries in this region.

New to ZOLL’s expanding product portfolio are the ZOLL AED 3™ automated external defibrillator* and the ZOLL AED 3 BLS* (basic life support). These AEDs build on ZOLL’s legacy of introducing new technology to the AED market to help improve outcomes for cardiac arrest patients. Enhanced Real CPR Help® gives rescuers the power to know when they are providing high-quality chest compressions. ZOLL has also introduced the world’s first 5-year universal CPR electrode for both adult and pediatric patients, further reducing the cost of ownership. Every ZOLL AED 3 comes with Program Management Onboard™, which can notify users immediately if the device fails a self-test, or if the battery is due to be replaced, ensuring the device is ready to be used.

The ZOLL AED 3 BLS model is designed specifically for the needs of first responders with the CPR Dashboard™ and the ability to deliver the patient record directly to health care providers.

Additional resuscitation solutions from ZOLL on display at Arab Health include:

Comprehensive Portfolio for Pre-hospital Care
ZOLL’s EMS products are designed to maximize care for the everyday situations that rescuers encounter. The small and lightweight X Series® monitor/defibrillator delivers unsurpassed monitoring and includes efficient and reliable solutions for patient data management and debriefing. It also provides system-independent STEMI management and has telemedicine capabilities. The new RapidShock™*• functionality is the fastest rhythm analysis in the world, giving the rescuer a shock/no shock decision in as little as 3 seconds.

The ResQCPR™ System is a combination of two medical devices, the CardioPump® ACD-CPR device and the ResQPOD® impedance threshold device (ITD). The devices are used together during CPR to create an enhanced vacuum in the chest that improves blood flow to the brain and vital organs. A large randomized controlled trial showed that the ResQCPR System improved long-term functional survival by 53%.1 The ResQPOD can also be used alone with high-quality CPR to improve outcomes.2

The AutoPulse® Resuscitation System is ZOLL’s automated CPR device. Designed for Resuscitation on the Move™, it delivers high-quality CPR whenever and wherever it’s needed especially during transport of critically ill patients. In a meta-analysis of 12 comparative clinical trials, the AutoPulse improved the odds of return of spontaneous circulation (ROSC) by 62% when compared to manual CPR.3 Shock Sync*• technology on the AutoPulse serves to limit the pauses in CPR and automatically times the shock to maximize the likelihood of shock success.

When used in the hospital, the AutoPulse helps staff achieve a more organized code when resources are constrained on nights and weekends, and in the cardiac catheterization lab it helps to keep staff members safe from radiation.

Resuscitation Solutions for the Hospital Environment
The R Series® monitor/defibrillator includes a CPR Dashboard that provides real-time feedback on compression quality, See-Thru CPR® to reduce the duration of pauses during CPR by filtering out CPR artifact, and EtCO2 to signal the earliest changes in patient condition. Post-event, comprehensive software solutions support continuous quality improvement.

ZOLL’s Intravascular Temperature Management (IVTM™) offers health care providers the precision and control they need to rapidly, safely, and effectively manage the core body temperature of critically ill or surgical patients. The Thermogard XP® delivers accurate, easy-to-use, and cost-effective control for both cooling and warming applications. This temperature management system provides a variety of catheter options depending upon the specific patient needs.

Ventilation Made Easy
The 731 family of portable ventilators offers the ideal solution for environments ranging from the emergency department to military operations, and every care environment in between. They provide a range of therapies to ventilate and support infants (≥5 kg) through adults. Built on a platform designed for mobility, all of ZOLL’s ventilators weigh less than 10 pounds (<4.5 kg) and feature an unprecedented 10-hour battery run-time. When it’s time to recharge, the built-in rapid charger can restore the charge in as little as two hours.

About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com), an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.

About Asahi Kasei
The Asahi Kasei Group (asahi-kasei.co.jp) is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.

1). Aufderheide TP, et al. Lancet. 2011;377(9762):301-311.
2). Yannopoulos D, et al. Resuscitation. 2015;94:106-113.
3). Westfall M, et al. Critical Care Medicine. 2013 Jul;41(7):1782‐9.

*Currently not available for sale or distribution in the US or Canada.
**Currently not available for sale or distribution in the US.

Copyright © 2017 ZOLL Medical Corporation. All rights reserved. AutoPulse, CardioPump, CPR Dashboard, IVTM, Program Management Onboard, RapidShock, Real CPR Help, ResQCPR, ResQPOD, Resuscitation on the Move, R Series, See-Thru CPR, Thermogard XP, X Series, ZOLL, and ZOLL AED 3 are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.

SCHOTT to Demo New Laser, IR Glass At Photonics West 2017

Submit the press release

 

At Photonics West 2017, SCHOTT is putting the future of medical technology, manufacturing, space exploration, and other fields on display. The international technology group will exhibit and demonstrate its ultra-thin glass SCHOTT AS 87 eco, IR glass IRG 27, and laser glass BLG 80, which were both developed and are now being produced in SCHOTT Advanced Optics’ Duryea, PA facility. SCHOTT’s Duryea location serves as the main site for optical systems technology in North America. In addition, SCHOTT experts will offer several technical paper discussions and a designer workshop for engineers and optical designers to learn the technical properties of laser and optical components. SCHOTT will attend Photonics West in San Francisco from Jan. 31 to Feb. 2 at booth #1314 in South Hall.

SCHOTT will display and demo its new IR broadband material IRG 27, which enables designers to realize new IR optical systems. IRG 27 offers excellent transmission from 680 nm in the visible range through the SWIR, MWIR, and LWIR wavelengths, and has no Germanium content, allowing minimal absorption at 12.5 μm. One major advantage is the near zero dn/dT across the entire SWIR (starting at 1.5 μm) through the MWIR and LWIR range. IRG 27 can be processed by conventional grinding and polishing, single point diamond turning, or molding. Join SCHOTT’s Gernot Weber for a demo of IRG 27 at the Demo Area 1 (Hall ABC South) on Jan. 31 at 1:30 pm.

In laser glass, SCHOTT will highlight its new BLG 80, which features broad emission bands, making it a cost-effective alternative to Ti:Sa. It replaces mixed silicate-phosphate systems for high powered lasers, and allows for novel new lasers with a more compact architecture. Todd Jaeger will show the many applications of SCHOTT’s laser materials on Feb. 1 at 11:30 a.m at the Demo Area 1 (Hall ABC South).

Both IRG 27 and BLG 80 were developed at SCHOTT’s facility in Duryea, Pennsylvania, and are now being produced there.

SCHOTT’s ultra-thin glass for mobile applications, SCHOTT AS 87 eco, is the the world’s first mass volume available, high strength, ultra-thin glass with no need for slimming. Its extremely high impact and bending strength, and resistance to scratches, make it tough despite its thinness. Offered in a range of ultra-thin thicknesses (70 to 350 μm), SCHOTT AS 87 eco has excellent transmission characteristics that create opportunities for wearables, smartphones, and sensors, among myriad other applications.

In addition to product demos, SCHOTT will present four technical papers throughout the show, covering various industrial and medical applications:

• “Lasing efficiency of Er-Yb-Cr-Glass: A temperature study” with Simi George on Jan. 30 at 11:00 am.
• “New gain materials for high-power laser applications” with Simi George on Jan. 31 at 2:00 pm.
• “Latest results on solarization of optical glasses with pulsed laser radiation” with Ralf Jedamzik on Jan. 31 at 5:05 pm.
• “IRG 27: A new glass type for multi-band IR optics” with Mark Davis on Feb. 1 at 10:00 am.

SCHOTT will also host an optical designer workshop. The sessions will include updates on optical materials, including glasses for outer space and other extreme environments, and those for applications beyond the visible spectrum.

“Photonics West brings together the best minds of the laser and infrared worlds,” said Steve Sokach, Sales Director North America at SCHOTT. “The future of both spaces offers tremendous promise for everything from medicine to transportation to space exploration, and more. SCHOTT will have its materials and a host of specialists and developers on hand to show how we can bring that future within reach.”

SCHOTT (schott.com) is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 34 countries. With its workforce of approximately 15,000 employees, sales of $2.21 billion were generated in fiscal year 2015/2016.

Passive Infrared Motion Sensor Market to Grow at CAGR of 10.74% by 2016-2020 – Key Vendors, Trends, Challenges, and Drivers, Analysis, & Forecasts

Submit the press release

Passive Infrared Motion Sensor Market report 2016-2020 focuses on the major drivers and restraints for the key players. Passive Infrared Motion Sensor research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.  The Passive Infrared Motion Sensor market research report is a professional and in-depth study on the current state of Passive Infrared Motion Sensor Industry.

Analysts forecast the global Passive Infrared Motion Sensor market to grow at a CAGR of 10.74% during the period 2016-2020.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Global Passive Infrared Motion Sensor market research report @ http://www.360marketupdates.com/10292848

The Passive Infrared Motion Sensor Market research report covers the present scenario and the growth prospects of the global Passive Infrared Motion Sensor industry for 2016-2020.

A PIR motion sensor detects infrared (IR) radiation to detect the presence of an object in its close proximity. Most objects with temperature exceeding absolute zero generally radiate heat energy at the wavelengths of infrared lights. A PIR-based sensor device does not generate any heat while detecting IR radiation. The sensors are capable of identifying the difference in IR radiations when an object is overlapping the primary subject of IR radiation detection. Benefits of using PIR motion sensors are that these sensors use less power and are rarely activated by airflow.

Key Vendors of Passive Infrared Motion Sensor Market:

  • Atmel Corporation
  • Honeywell International
  • Murata Manufacturing
  • Panasonic Corporation
  • Robert Bosch GmbH

And many more…

Get Sample PDF of Passive Infrared Motion Sensor Market Report@

http://www.360marketupdates.com/enquiry/request-sample/10292848

Passive Infrared Motion Sensor market report provides key statistics on the market status of the Passive Infrared Motion Sensor manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Passive Infrared Motion Sensor industry.

The Passive Infrared Motion Sensor market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the market. Passive Infrared Motion Sensor market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.

Regions of Passive Infrared Motion Sensor market:

  • Americas
  • APAC
  • EMEA

Through the statistical analysis, the report depicts the global Passive Infrared Motion Sensor market including capacity, production, production value, cost/profit, supply/demand and import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

Purchase Report @ http://www.360marketupdates.com/purchase/10292848

Key questions answered in Passive Infrared Motion Sensor market report:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

For Any Query, Contact Our Expert @ http://www.360marketupdates.com/enquiry/pre-order-enquiry/10292848

Market driver

  • Energy-saving ability of PIR motion sensors in lighting systems

Market challenge

  • Price-level sensitivity

Market trend

  • Increasing number of connected devices through IoT

The report then estimates 2016-2020 market development trends of Passive Infrared Motion Sensor market. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Passive Infrared Motion Sensor market before evaluating its feasibility.

Price of Report: $2500 (Single User License)

Ask for Discount @ http://www.360marketupdates.com/enquiry/request-discount/10292848

List of Exhibits in Passive Infrared Motion Sensor market report:

  • Exhibit 01: Product offerings
  • Exhibit 02: Impact of drivers
  • Exhibit 03: Impact of drivers and challenges
  • Exhibit 04: Key countries in each region
  • Exhibit 05: Global Passive Infrared Motion Sensor market shares by geographies 2015
  • Exhibit 06: Global Passive Infrared Motion Sensor market shares by geographies 2020
  • Exhibit 07: Geographical segmentation by revenue 2015

And continued….

 

About 360 Market Updates:
360 Market Sales Updates is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

 

Contact–
Mr. Ameya Pingaley
360 Market Sales Updates
+1 408 520 9750
Email – sales@360Marketupdates.com